Newsstand Menu

2022 Double Helix Medal winner Dr. Jennifer A. Doudna

Print Friendly, PDF & Email

CRISPR-Cas9 gene editing has changed the course of human and agricultural genetics research. In this video, 2022 Double Helix Medal winner Dr. Jennifer A. Doudna offers insights on the many applications of this revolutionary technology.

Doudna and her collaborator Emmanuelle Charpentier received the 2020 Nobel Prize in Chemistry for the development of CRISPR-Cas9. The groundbreaking tool allows scientists to alter DNA with the precision of a scalpel. This has proven invaluable across a range of research areas at Cold Spring Harbor Laboratory (CSHL), including genetic diseases, cancer, and agriculture.

Since 2015, CSHL has partnered with Doudna to host a conference called Genome Engineering: CRISPR Frontiers. The meeting brings scientists together to share ideas on the applications and ethics of gene editing.

Watch the video above to learn more about CRISPR’s massive impact and what it means for the future of genetics research.

Read the related story: 17th CSHL Double Helix Medals dinner raises $5.8 million